Clark+Elbing, LLP
Patent reexamination counsel·4 ex parte reexams
Clark+Elbing, LLP has served as patent-owner counsel in 4 USPTO ex parte reexaminations. The firm most often represents The General Hospital Corporation and Modernatx Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top patent owners represented
Outcome track record
How this firm's reexams resolve once a certificate issues: all claims confirmed, amended, mixed, or canceled.
- Certificate outcome split across every bucket
- Share of proceedings where claims survived
Practice metrics
Certificate rate, average pendency, and the open/closed split across the firm's full reexam docket.
- Certificate rate of closed proceedings
- Average pendency in months
Examiners & adversaries
Which examiners most often decide this firm's reexams, and which requesters most often challenge its patents.
- Most frequent examiners
- Top opposing requesters
Recent reexaminations (4)
| Control # | Filed | Patent | Title | Owner | Status |
|---|---|---|---|---|---|
| 90/014,394 | Oct 23, 2019 | 9,675,668 | Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 2 | Modernatx Inc. | Closed |
| 90/012,683 | Sep 15, 2012 | 8,123,663 | EXERCISE APPARATUS AND APPAREL | — | Closed |
| 90/012,335 | Jun 22, 2012 | 5,786,464 | OVEREXPRESSION OF MAMMALIAN AND VIRAL PROTEINS | The General Hospital Corporation | Closed |
| 90/012,334 | Jun 1, 2012 | 6,114,148 | HIGH LEVEL EXPRESSION OF PROTEINS | The General Hospital Corporation | Closed |
Other reexam law firms
See the full reexam picture for Clark+Elbing, LLP
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.